TTP moves to newly completed and expanded facility
Independent technology and product development company — TTP — has moved into the newly completed expansion of its life sciences development facility.
The expanded facility — multi-disciplinary suite of lab space — provides a Class II bio-handling and tissue culture laboratory and a dedicated facility for diagnostic system development under ISO 13485:2016.
“We have designed these facilities to address the evolving nature of the programmes we are undertaking,” said Piers Harding, Life Science Engineering manager at TTP. “The Class II facility now allows for TTP teams to undertake assay development and functional tests of systems with disease-pertinent samples. As our biological team has grown, this is something our clients have increasingly asked for. The expansion will work hand in hand with our molecular biology and bioengineering space — increasingly we are seeing programmes make use of the nearby micro-fabrication facility we established at TTP last year.”
“This is part of TTP’s ongoing investment in life sciences to provide our clients with interdisciplinary insight throughout the product development pathway,” explained Giles Sanders, of Life Sciences Business Development. “Our life sciences team has nearly doubled in size in the last few years, and this has been augmented by investments in equipment and robotics as well as internal programmes targeted at developing new technologies to provide our clients with a competitive advantage in their future products. This includes not only our Desktop Biology programmes but also the development of unique cell sorting technologies and a biomolecule innovation team focusing on solutions for bacterial concentration and developing constructs for super-stable and robust antibody analogues.”
These new facilities form part of the company’s ongoing investment into dedicated space for system development programmes for life science and diagnostics companies, and a growing initiative to find biologically derived solutions for challenges in assay development and biomarker discovery.